Research 2022

1. Al-Moundhri M, Cubisino A, Panaro F. Hepatocellular carcinoma with complete response to the immunotherapy: the oncologist’s dilemmaHepatobiliary Surg Nutr. 2022 Feb;11(1):119-122. doi: 10.21037/hbsn-21-499. PMID: 35284505 Free PMC article. No abstract available.
2. Al Farai A, Al Moundhri M, Panaro F. Launching of the Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC) in the Sultanate of Oman to manage HBP type of cancers. Hepatobiliary Surg Nutr. 2022 Apr;11(2):338-339. doi: 10.21037/hbsn-2022-03. PMID: 35464280; PMCID: PMC9023832.
3. Al-Shandudi M, Al-Moundhri M, Chan MF, Al-Hajri T, Al-Balushi M, Al-Azri M. Health-Related Quality of Life, Functioning, and Physical Symptoms of Adult Omani Colorectal Cancer Survivors. Asian Pac J Cancer Prev. 2022 Sep 1;23(9):3019-3027. doi: 10.31557/APJCP.2022.23.9.3019.  PMID: 36172664.
4. Al Saqri A, Malgundkar SH, Al Kindi F, Gupta I, Al Moundhri M, Tamimi Y. SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.  Hum Cell. 2022 Jul;35(4):1114-1125. doi: 10.1007/s13577-022-00715-3. Epub 2022 May 21.
5. Al-Riyami I, Al-Khabori M, Al Balushi K, Al-Zadjali S, Al-Rawahi M, Dennison D, Al-Hunaini M, Al-Rawas A, Al-Moundhri M. Impact of Glutathione S-Transferase Polymorphisms on Busulfan Pharmacokinetics and Outcomes of Hematopoietic Stem Cell Transplantation.  Ther Drug Monit. 2022 Aug 1;44(4):527-534. doi: 10.1097/FTD.0000000000000957.
6. AlZaabi A, AlAmri H, ALAjmi G, Allawati M, Muhanna M, Alabri R, AlBusaidi F, AlGhafri S,   Al-Mirza A, Al Baimani K. (November 30, 2021) Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients. Cureus 13(11): e20030. doi:10.7759/cureus.20030.
7. Anke Smits, Khadra Galaal, Steve Winnan, Alberto Lopes and Ruud L. M. Bekkers. Feasibility and Effectiveness of the Exercise Program in Endometrial Cancer; Feasibility and Acceptability Survivorship Trial (EPEC-FAST). Cancers 2022, 14(22), 5579; https://doi.org/10.3390/cancers14225579 – 14 Nov 2022.
8. Nawal Al Mahyijari, Dr. Aya Moshtohry, Rafiaa Al Mamari and Marwa Al Farsi. Practical considerations and challenges in establishing a de novo integrative holistic cancer care service in a national cancer center.  International Journal of Research in Psychiatry 2022; 2(1): 26-31    DOI: https://doi.org/10.22271/27891623.2022.v2.i1a.25.
9. Khan SA, Burney IA. Managing the backlog of cancer care due to COVID-19: A Perspective from low-to-middle income countries (LMICs). LNJCC. 2021; 3(1): 1-2
10. Al Lawati M, Ahmed N, Burney IA. Prognostic factors for pulmonary metastasectomy in soft tissue sarcoma: An Integrative review. LNJCC. 2021; 3(1): 14-18.
11. Burney IA, Galerani-Lopez AP. Frequency of Gynecological cancers – A right step in the right direction. Letter to the Editor. LNJCC. 2021; 3(1): 21-22.
12. Jayakrishnan, Al Moundhri, M, Burney I, al Hashmi Z, Al Bimani K. Pulmonary toxicities of immune checkpoint inhibitors in the management of cancer: mini review. Adv Respir Med. 2022; 90: 219-229.
13. Burney IA, Ahmad N. Artificial Intelligence in Medical Education: A citation-based systematic literature review. JSTMU. 2022; 5(1).
14. Othman A, Kumar S, Qureshi A, Java Z, Burney IA. Durable response to pazopanib in a patient with fumarate dehydrogenase mutant tubulocystic renal cell carcinoma. Journal of Case Reports. Accepted for publication.
15. Primary Author: Ayaad O, Al-Dewiri, R., Kasht, L., Qaddumi, B., & Ayyad, M. (2022). Adopting lean management in quality of services, cost containment, and time management. Asian Pacific Journal of Cancer Prevention, 2022, 23.8: 2835-2842.
16. Primary Author: Ayaad, O., Al-Ruzzieh, M. A., Qaddumi, B., Al Hroub, A., Ayyad, M., Abuseif, S., & Çelik, Y. Outsourcing services in the healthcare sector: balancing risks and benefits. British Journal of Healthcare Management, 2022, 28.3: 96-103.‏‏
17. Corresponding author: Al-Ruzzieh, M. A., Ayaad O, . Measuring Occupational Fatigue among Higher and Middle Management at a Specialized Cancer Center during the COVID-19 Pandemic. Asian Pacific Journal of Cancer Prevention, 2022, 23.10: 3265-3271.
18. ‏Corresponding author: Al-Ruzzieh, M. A., AL-rifai, A, Ayaad O.  Organisational citizenship behaviour in the healthcare workplace: a scoping review. British Journal of Healthcare Management, 2022, 28.6: 1-7.
19. ‏Corresponding author: Ayyad, M., Ayaad, O., Alkhatatbeh, H., Sawaqed, F., & Al-Rawashdeh, S. (2022). Laparoscopic partial nephrectomy: off-clamp versus on clamp. Asian Pacific Journal of Cancer Prevention, 23(5), 1719-1723.
20. Corresponding author: Haroun, A., Ayaad, O., Al-Ruzzieh, M. A., & Ayyad, M. The role of total quality management in improving patient experiences and outcomes. British Journal of Healthcare Management, 2022, 28.10: 1-8 
21. Co-author: Alloubani, A., Nimer, R. M., Ayaad, O., Farhan, F., Samara, R., Abdulhafiz, I., … & Akhu-Zaheya, L. “Prevalence and knowledge of cardiovascular disease risk factors among young adults in Saudi Arabia.” Obesity Medicine 36 2022: 100457.

CovidSurg-3: Outcomes of Surgery in Covid-19 Infection (Covidsurg-3) Multicentre clinical trial, total recruited 2000 participants  

(Dr. Sonali Kodange, Intensive Care, SQCCCRC)

1. A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice (IMreal)

(Prof. Mansour Al Moundhri, Medical Oncology, SQCCCRC)

2. A protocol for multiple phase 3 multi-centre randomised, registry, embedded, single blinded clinical trials comparing conservative oxygen therapy to liberal oxygen therapy in mechanically ventilated adults in the intensive care unit nested within a 40,000-patient mega trial (Mega-ROX) (Dr. Airton Leonardo, Intensive Care, SQCCCRC )
3. Sedation practice in intensive care evaluation randomised controlled trial: SPICE IV Study

(Dr. Airton Leonardo, Intensive Care, SQCCCRC )

4. REtroperitoneal SArcoma (RESAR): prospective collection of primary retroperitoneal sarcoma patient’s data, radiological and pathological material for the TransAtlantic Australasian Retroperitoneal Sarcoma Working Group

(Dr. Boris Itkin, Medical Oncology, SQCCCRC)

1. Effect of Molecular Markers on Fluorouracil and Capecitabine Pharmacokinetics and Clinical Outcomes

(Ms. Bushra Mustafa, Pharmacy, SQCCCRC_

2. Overcoming chemotherapy resistance in gynecological cancers using Marine Natural Product: putative role of miRNA expression

(Dr. Ikram, Medical Oncology, SQCCCRC)

3. Direct sterility testing using a Closed System Transfer Device (CSTD) on biological therapy

(Ms. Maha Hassan, Pharmacy, SQCCCRC)

4. Establishment of Diagnostic Reference Levels (DRLs) for Adult in Nuclear Medicine Imaging in Sultan Qaboos Comprehensive Cancer Care and Research Centre.

(Ms. Noura AL Makhmari, Radiology, SQCCCRC)

5. Melanoma in Oman. (MIO) Focus on sun unexposed melanoma. Mixed cohort study.

(Dr. Boris Itkin, Medical Oncology, SQCCCRC)

6. Predictive molecular biomarkers for response to neoadjuvant FLOT4 chemotherapy in locally advanced resectable gastric or gastro-esophageal junction adenocarcinoma using Multi-Omics analysis

(Prof. Mansour Al Moundhri, SQCCCRC)

7. Clinical utility of molecular profiling in rare tumors in the real-world setting. Cohort study – “CLEAR”. Protocol. Version 1.0 Proposal

(Dr. Bois Itkin, Medical Oncology, SQCCCRC_)

8. Patterns of Toxicity with Immune Checkpoint Inhibitors in Solid Tumors: Real-world Experience from a Tertiary Care Centre in Oman

(Mr. Nameer  AlWard, Pharmacy, SQCCCRC_)